BioSpace News Archive

ORIC Pharmaceuticals, Inc. announced that on September 1, 2023, ORIC granted a total of 19,380 non-qualified stock options and 3,220 restricted stock units to three new non-executive employees who began their employment with ORIC in August 2023.

Zentalis® Pharmaceuticals, Inc. announced that on September 1, 2023, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 32,975 shares of the Company’s common stock to four newly hired employees.

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, announced multiple presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023 being held August 29 - September 1, 2023, in Jerusalem, Israel.

Cutera, Inc. announced that on August 17,2023 the Compensation Committee of Cutera’s Board of Directors approved the grant of inducement awards to Jeffrey Jones, who joined Cutera on August 28, 2023, as the Chief Operating Officer.

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing.

CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data confirming the utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher disease (GD).

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc.

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST.

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company) developing a new class of synthetic anti-infectives, is pleased to report further patient case studies utilizing its lead anti-infective candidate, RECCE® 327.

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 12, 2023 at 11:30 a.m. ET.